Your browser doesn't support javascript.
loading
Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.
Kemper, Marcel; Evers, Georg; Schulze, Arik Bernard; Sperveslage, Jan; Schülke, Christoph; Lenz, Georg; Herold, Thomas; Hartmann, Wolfgang; Schildhaus, Hans-Ulrich; Bleckmann, Annalen.
Afiliação
  • Kemper M; Department of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Muenster, 48149 Muenster, Germany.
  • Evers G; West German Cancer Center, Sites Muenster & Essen, 45147 Essen, Germany.
  • Schulze AB; Authors share first authorship.
  • Sperveslage J; Department of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Muenster, 48149 Muenster, Germany.
  • Schülke C; West German Cancer Center, Sites Muenster & Essen, 45147 Essen, Germany.
  • Lenz G; Authors share first authorship.
  • Herold T; Department of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Muenster, 48149 Muenster, Germany.
  • Hartmann W; West German Cancer Center, Sites Muenster & Essen, 45147 Essen, Germany.
  • Schildhaus HU; Gerhard-Domagk-Institute of Pathology, University Hospital Muenster, 48149 Muenster, Germany.
  • Bleckmann A; Institute of Clinical Radiology, University Hospital Muenster, 48149 Muenster, Germany.
Oncotarget ; 12(19): 1946-1952, 2021 Sep 14.
Article em En | MEDLINE | ID: mdl-34548910
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha